ES2054011T3 - Un proceso para la preparacion de un compuesto, "leualacina". - Google Patents

Un proceso para la preparacion de un compuesto, "leualacina".

Info

Publication number
ES2054011T3
ES2054011T3 ES89308901T ES89308901T ES2054011T3 ES 2054011 T3 ES2054011 T3 ES 2054011T3 ES 89308901 T ES89308901 T ES 89308901T ES 89308901 T ES89308901 T ES 89308901T ES 2054011 T3 ES2054011 T3 ES 2054011T3
Authority
ES
Spain
Prior art keywords
compound
leualacina
preparation
hapsidospora
leualacin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89308901T
Other languages
English (en)
Inventor
Kiyoshi C O Sankyo Comp Hamano
Kouhei C O Sankyo Compa Furuya
Kazuhiko C O Sankyo Co Tanzawa
Takeshi C O Sankyo Co Kagasaki
Masaaki C O Sankyo Co Miyamoto
Takeshi C O Sankyo C Kinoshita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Application granted granted Critical
Publication of ES2054011T3 publication Critical patent/ES2054011T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/80—Antihypertensive peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

UN COMPONENTE NUEVO, QUE HEMOS LLAMADO "LEUALACIN" TIENE LA FORMULA (I): Y DEBE SER PREPARADO POR CULTIVACION DE UN MICROORGANISMO DEL GENERO HAPSIDOSPORA, ESPECIALMENTE HAPSIDOSPORA IRREGULARIS. EL COMPONENTE DEBE SER USADO PARA EL TRATAMIENTO Y PROFILAXIS DE ENFERMEDADES Y TRASTORNOS CARDIOVASCULARES, ESPECIALMENTE HIPERTENSION.
ES89308901T 1988-09-05 1989-09-01 Un proceso para la preparacion de un compuesto, "leualacina". Expired - Lifetime ES2054011T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP22196088 1988-09-05

Publications (1)

Publication Number Publication Date
ES2054011T3 true ES2054011T3 (es) 1994-08-01

Family

ID=16774855

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89308901T Expired - Lifetime ES2054011T3 (es) 1988-09-05 1989-09-01 Un proceso para la preparacion de un compuesto, "leualacina".

Country Status (6)

Country Link
US (1) US5112807A (es)
EP (1) EP0358418B1 (es)
AT (1) ATE83480T1 (es)
DE (1) DE68903907T2 (es)
ES (1) ES2054011T3 (es)
GR (1) GR3007079T3 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9302046D0 (en) * 1993-02-03 1993-03-24 Pharma Mar Sa Antiumoral compound-v
US5461070A (en) * 1994-08-29 1995-10-24 The Regents Of The University Of California Anti-flammatory method using indole alkaloids
DK2376101T3 (en) 2008-12-29 2016-01-18 Trevena Inc BETA-arrestin effectors AND COMPOSITIONS AND METHODS FOR USE THEREOF
AU2013215269A1 (en) * 2012-01-31 2014-08-21 Trevena, Inc. Beta-arrestin effectors and compositions and methods of use thereof
JP2017506235A (ja) 2014-02-07 2017-03-02 トレベナ・インコーポレイテッドＴｒｅｖｅｎａ， Ｉｎｃ． ベータ−アレスチンエフェクターの結晶性および非晶質形態
AU2015264367A1 (en) 2014-05-19 2016-12-15 Trevena, Inc. Synthesis of Beta-Arrestin Effectors
CN106892875B (zh) * 2016-11-11 2018-03-02 杭州唯铂莱生物科技有限公司 钙离子通道阻滞剂化合物及其制备方法和应用
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2108106B (en) * 1978-07-04 1983-09-01 Shell Int Research Novel macrocyclic compounds and salts thereof useful for dissolving barium sulphate scale
SU1219587A1 (ru) * 1978-09-29 1986-03-23 Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латвсср Циклические аналоги каллидина и других пахикининов,обладающие пролонгированным гипотензивным действием в сочетании с низкой или полностью отсутствующей миотропной активностью

Also Published As

Publication number Publication date
ATE83480T1 (de) 1993-01-15
GR3007079T3 (es) 1993-07-30
EP0358418A1 (en) 1990-03-14
DE68903907D1 (de) 1993-01-28
US5112807A (en) 1992-05-12
DE68903907T2 (de) 1993-06-09
EP0358418B1 (en) 1992-12-16

Similar Documents

Publication Publication Date Title
FI906438A0 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten A-nor-steroidi-3-karboksyylihappojohdannaisten valmistamiseksi
EP0398753A3 (en) Metalloproteinase inhibitor
ES2083392T3 (es) Sustancia pf 1022, procedimiento para su preparacion y composicion antihelmintica que contiene esta sustancia.
NO944644D0 (no) Fremstilling av 3,4,4-trisubstituert-piperidinyl-N-alkylkarboksylater og mellomprodukter
ATE78031T1 (de) Prostaglandin-derivate zur behandlung von glaucoma oder augenueberdruck.
AU2292088A (en) Cathartics
GR3030718T3 (en) Novel prostaglandin analogue.
ES2052714T3 (es) Un proceso para la preparacion de un compuesto denominado "cornexistina".
EP0405116A3 (en) Phenylalkan(en)oic acids
ES2054011T3 (es) Un proceso para la preparacion de un compuesto, "leualacina".
BR9200627A (pt) Processo para a preparacao de um composto e composto obtido
ATE86960T1 (de) Cyclopropanderivate.
DZ1414A1 (fr) Dérivés de la thiéno-triazolo-diazépine, ainsi qu'un procédé de préparation desdits composés.
DZ1407A1 (fr) Dérivés d-substitués des n,n'-ditriméthoxybenzoylepipérazine ainsi que leur procédé de préparation.
ATE98230T1 (de) Indolderivate.
FI901277A0 (fi) 2,5,6,7-tetranor-4,8-inter-m-fenylen pg1z-derivativ.
AU7066287A (en) Pharmaceutical compositions containing 5-phenyl-1, 3-dioxoalkenyl compounds
MX9205408A (es) Metodo para tratar hipertension.
FI941850A (fi) Uusi yhdiste, joka on leustroduksiini H, sen valmistus ja terapeuttinen käyttö
IT1247508B (it) Composizioni farmaceutiche contenenti l'estere 4-(2 metilamminoetil)- 1,2- fenilenicodell`acido 2-metilpropanoico per il trattamento della neurootticopatia glaucomatosa
ES2038601T3 (es) Procedimiento para preparar 4-androsten-3,17-diona y 1,4-androstadien-3,17-diona.
ES2039270T3 (es) Derivados de gamma-l-glutamil-4-nitroanilida y procedimiento para determinar actividad de gamma-gtp utilizandolos.
SU1626642A1 (ru) 3-Алкил-4-метил-2,9-диоксо-3,8-диазабицикло[4,3,0]нона-1(6), 4-диенилийперхлораты, обладающие противовоспалительным действием
ES2059702T3 (es) Politioureas, procedimiento para su fabricacion y empleo de estas politioureas para evitar o reducir la formacion de costras en reactores.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 358418

Country of ref document: ES